Search Results

You are looking at 1 - 10 of 162 items for :

  • "Cervical cancer" x
Clear All
Full access

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, David Cohn, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Robert L. Giuntoli II, Ernest Han, Warner K. Huh, John R. Lurain III, Lainie Martin, Mark A. Morgan, David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Nicole R. McMillian and Miranda Hughes

estimated 12,200 new cases of carcinoma of the uterine cervix (ie, cervical cancer) were diagnosed in the United States in 2012, and 4200 people died of the disease. 1 , 2 Cervical cancer rates are decreasing among women in the United States, although

Full access

Benjamin E. Greer, Wui-Jin Koh, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Warner K. Huh, Daniel S. Kapp, John R. Lurain III, Lainie Martin, Mark A. Morgan, Robert J. Morgan Jr., David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr., Nelson Teng and Fidel A. Valea

Overview A n estimated 12,200 new cases of cervical cancer will be diagnosed in the United States in 2010, and 4200 people will die of the disease. 1 Cervical cancer rates are decreasing among women in the United States, although incidence

Full access

Edward E. Partridge, Nadeem R. Abu-Rustum, Susan M. Campos, Patrick J. Fahey, Michael Farmer, Rochelle L. Garcia, Anna Giuliano, Howard W. Jones III, Subodh M. Lele, Richard W. Lieberman, Stewart L. Massad, Mark A. Morgan, R. Kevin Reynolds, Helen E. Rhodes, Diljeet K. Singh, Karen Smith-McCune, Nelson Teng, Cornelia Liu Trimble, Fidel Valea and Sharon Wilczynski

women without access to health care and those who have immigrated to the United States from countries where cervical cancer screening is not routinely performed. 2 Because cervical cytology screening is the current method for early detection of this

Full access

Wui-Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, Rachel Clark, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian and Jillian L. Scavone

GUIDELINES® : Cervical Cancer, Version 3.2019 Version 3.2019 12/17/18 © National Comprehensive Cancer Network, Inc. 2019 All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written

Full access

Michael Xiang and Elizabeth A. Kidd

Background Cervical cancer is commonly viewed as a disease affecting younger women. However, age at diagnosis follows a bimodal distribution, with peaks at 30 to 39 years and 60 to 69 years. 1 When hysterectomy is taken into account, the highest

Full access

Lyndsay J. Willmott, Daniele A. Sumner and Bradley J. Monk

Epidemiology In the United States, 11,270 new cases of cervical cancer and 4070 associated deaths occurred in 2009. 1 These numbers represent a significant decline in incidence and prevalence that is attributed to excellent screening

Full access

Edward E. Partridge, Nadeem Abu-Rustum, Anna Giuliano, Stewart Massad, Joan McClure, Mary Dwyer and Miranda Hughes

recent changes to cervical cancer screening recommendations and management of abnormal screening test results Describe the rationale behind the recent changes in management for cervical cancer screening Overview Cervical cytology screening

Full access

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, Kathleen R. Cho, Christina Chu, David Cohn, Marta Ann Crispens, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain III, David Mutch, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Catheryn M. Yashar, Nicole R. McMillian and Jillian L. Scavone

, participants will be able to: Integrate into professional practice the updates to the NCCN Guidelines for Cervical Cancer Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Cervical Cancer

Full access

David H. Moore

DH . Combined chemotherapy and radiation therapy for cervical cancer . J Natl Compr Canc Netw 2004 ; 2 : 631 – 635 . 12. National Cancer Institute . Concurrent chemoradiation for cervical cancer . Clinical Announcement , Washington

Full access

David H. Moore

and IV cervical cancer confined to the pelvis . Int J Radiat Oncol Biol Phys 1979 ; 5 : 317 – 322 . 7 Berry RJ . Effects of some metabolic inhibitors on x-ray dose-response curves for the survival of mammalian cells in vitro, and on